Quarterly report [Sections 13 or 15(d)]

Note 8 - Accrued Liabilities

v3.26.1
Note 8 - Accrued Liabilities
3 Months Ended
Mar. 31, 2026
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8.

Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

   

March 31, 2025

   

December 31, 2025

 

Clinical trial costs

  $ 1,399     $ 1,291  

Compensation

    741       1,380  

Research and development services

    130       749  

Professional services fees

    64       120  

Other

    6       5  

Total accrued liabilities

  $ 2,340     $ 3,545